aldosterone has been researched along with paricalcitol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YW; Nakane, M; Wolf, M; Wu-Wong, JR | 1 |
| Egido, J; Morgado-Pascual, JL; Ortiz, A; Rayego-Mateos, S; Ruiz-Ortega, M; Valdivielso, JM | 1 |
2 other study(ies) available for aldosterone and paricalcitol
| Article | Year |
|---|---|
Differential effects of vitamin d receptor agonists on gene expression in neonatal rat cardiomyocytes.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Aldosterone; Animals; Animals, Newborn; Blotting, Western; Calcifediol; Calcitriol; Ergocalciferols; Gene Expression Regulation; Humans; Polymerase Chain Reaction; Rats; Receptors, Calcitriol; Steroid Hydroxylases; Vitamin D3 24-Hydroxylase | 2011 |
Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells.
Topics: ADAM Proteins; ADAM17 Protein; Aldosterone; Cell Line; Cell Proliferation; Epithelial Cells; ErbB Receptors; Ergocalciferols; Gene Expression Regulation; Humans; Inflammation; Kidney Tubules; Receptors, Calcitriol; Renal Insufficiency, Chronic; Renin-Angiotensin System; Signal Transduction; STAT1 Transcription Factor; Transforming Growth Factor alpha; Vitamin D Deficiency | 2015 |